Tags
healthcare
medicine
drug
pharmaceutical
pharma
regulatory affairs
united kingdom
europe
australia
regulatory
row countries
mhra
tga
regulatory requirements
barriers for protein delivery
function
advantages
need
instability of protein and peptide
physicochemical properties of peptide and proteins
peptide and protein structure
uidelines
multidisciplinary g
efficacy guidelines
safety guidelines
quality guidelines
mission
introduction
Mehr anzeigen
Präsentationen
(3)Gefällt mir
(3)Regulatory requirement of EU, MHRA & TGA
AshwiniBawankule
•
Vor 3 Jahren
Quality by-Design (QbD) by Mr. Nitin Kadam.
Nitin Kadam
•
Vor 11 Jahren
Herbal drug regulations
Dr Priyanka Goswami
•
Vor 7 Jahren
Tags
healthcare
medicine
drug
pharmaceutical
pharma
regulatory affairs
united kingdom
europe
australia
regulatory
row countries
mhra
tga
regulatory requirements
barriers for protein delivery
function
advantages
need
instability of protein and peptide
physicochemical properties of peptide and proteins
peptide and protein structure
uidelines
multidisciplinary g
efficacy guidelines
safety guidelines
quality guidelines
mission
introduction
Mehr anzeigen